Description Module
The Description Module contains narrative descriptions of the clinical trial, including a brief summary and detailed description. These descriptions provide important information about the study's purpose, methodology, and key details in language accessible to both researchers and the general public.
Description Module path is as follows:
Study -> Protocol Section -> Description Module
Description Module
Ignite Creation Date:
2025-12-24 @ 9:33 PM
Ignite Modification Date:
2025-12-24 @ 9:33 PM
NCT ID:
NCT07148232
Brief Summary:
This study is investigating tobacco use and providing tobacco treatment among people experiencing homelessness in California, in San Francisco and Los Angeles.
Detailed Description:
PRIMARY OBJECTIVES:
I. Biochemically verified 7-day point prevalence tobacco abstinence at 6-months follow-up.
II. Use expired carbon monoxide (CO) to confirm self-reports of abstinence using a cut-off of CO ≤5 parts per million (ppm).
SECONDARY OBJECTIVES:
I. Biochemically-verified 7-day point prevalence tobacco abstinence at 3-months follow-up.
II. Measured at 6-months follow-up, a total number of expired carbon monoxide (CO-negative samples).
III. Measured at 6-months follow-up, longest duration of abstinence (i.e., total number of uninterrupted days abstinent), proportion with 50% reduction in expired CO for those who do not quit smoking.
IV. Use expired CO to confirm self-reports of abstinence using a cut-off of CO ≤5 ppm.
OUTLINE:
Participants will be randomized to one of two groups:
* Intervention group receives 6 months of pharmacist consultation, monthly delivery of nicotine replacement therapy, and telephone wellness coaching.
* Control group receives pharmacist consultation and monthly delivery of nicotine replacement therapy for 3 months.
Participants will be followed up at 1, 3 and 6 months.
Study:
NCT07148232
Study Brief:
Protocol Section:
NCT07148232